Immunodetectable cyclin D1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions

British Journal of Cancer

Volumn 84, Issue 8, 2001, Pages 1064-1069

  Shoker, B S ^a   Jarvis, C ^a   Davies, M P A ^b   Iqbal, M ^b   Sibson, D R ^b   Sloane, J P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b CLATTERBRIDGE HOSPITAL   (United Kingdom)

Author keywords

Benign breast; Breast cancer; Cyclin D1; Ki67; Oestrogen receptor

Indexed keywords

CYCLIN D; ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER GROWTH; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; PATHOGENESIS; PRECANCER AND CANCER-IN-SITU; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BREAST; BREAST NEOPLASMS; CYCLIN D1; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MITOSIS; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN;

EID: 0035917617     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1705     Document Type: Article

References (22)

1. Alle KM, Henshall SM, Field AS and Sutherland RL (1998) Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4: 847-854
2. Baak JPA and Oort J (1983) A manual of morphometry in diagnostic pathology Springer: Heidelberg, Berlin, New York
3. 1 in mammary carcinoma. J Pathol 181: 267-269
4. Clarke RB, Howell A, Potten CS and Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991
5. de Jong JS, van Diest PJ, Michalides RJAM and Baak JPA (1999) Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. J Clin Pathol: Mol Pathol. 52: 78-83
6. Gillett CE, Lee AHS, Millis RR and Barnes DM (1998) Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184: 396-400
7. Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doki Y, Cacace AM, Schieren I and Weinstein IB (1995) Stable overexpression of cyclin D1 in human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10: 953-961
8. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J and Roos G (1997) Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 57: 549-554
9. Leong AC, Hanby AM, Potts HW, Tan DS, Skilton D, Ryder K, Harris WH, Liebmann RD, Barnes DM and Gillett CE (2000) Cell cycle proteins do not predict outcome in grade 1 infiltrating ductal carcinoma of the breast. Int J Cancer 89: 26-31
10. Mommers ECM, van Diest PJ, Leonhart AM, Meijer CJLM and Baak JPA (1998) Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. Hum Pathol 29: 1539-1545
11. National co-ordinating group for breast screening pathology (1997) Pathology reporting in breast cancer screening 2nd edn. NHSBSP Publications No 3 Sheffield, UK
12. Page DL and Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23: 1095-1097
13. Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MPA, Sibson DR and Sloane JP (1999a) Oestrogen receptor- positive proliferating cells in the normal and precancerous breast. Am J Pathol 155: 1811-1815
14. Shoker BS, Jarvis C, Sibson DR, Walker C and Sloane JP (1999b) Oestrogen receptor expression in the normal and precancerous breast. J Pathol 188: 237-244
15. Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MPA, Sibson DR and Sloane JP (2000) Abnormal regulation of oestrogen receptor in benign breast lesions. J Clin Pathol 53: 778-783
16. Sutherland RL, Hamilton JA, Sweeney KJE, Watts CKW and Musgrove EA (1995) Expression and regulation of cyclin genes in breast cancer. Acta Oncol 34: 651-656
17. van Diesl PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, Meijer CJ and Baak JP (1997) Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 150: 705-711
18. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671
19. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawerence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL and Steeg PS (1995) Overexpression of cyclin D messenger RNA distinguishes invasive and in situ breast carcinomas from non malignant lesions. Nat Med 1: 1257-1260
20. Zajchowski DA, Sager R and Webster L (1993) Oestrogen inhibits the growth of oestrogen receptor-negative, but not oestrogen receptor-positive, human mammary epithelial cells expressing a recombinant oestrogen receptor. Cancer Res 53: 5004-5011
21. Zhu XL, Hartwick W, Rohan T and Kandel R (1998) Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 11: 1082-1088
22. Zwijsen RML, Wientjens E, Klompmaker R, van der Sman J, Bernards R and Michalides RJAM (1997) CDK-independent activation of oestrogen receptor by cyclin D1. Cell 88: 405-415